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Abstract - The stability of aspartate aminotransferase (AST), lactate dehydrogenase (LDH), tartrate resistant acid phos-
phatase (TRAP) and alkaline phosphatase (ALP) activities from saliva and gingival crevicular fluid (GCF) with and with-
out the addition of protease inhibitor (PI) at room temperature (RT; 25⁰C), 4°C and -20°C were investigated. AST, LDH, 
TRAP and ALP activities in saliva and GCF (n=9) with and without the addition of PI were assayed at 0 (control), 12, 24, 
48, 72 h, one and two weeks. A paired t-test showed there were a significant differences (p<0.05) between LDH and TRAP 
activities in saliva, in the presence and without PI at all temperatures. ALP activity exhibited a significant difference in 
activity (p<0.05) in the presence and without PI at RT while no significant differences were observed at 4⁰C and -20⁰C. A 
significant difference (p<0.05) was observed in AST, LDH and TRAP activities (GCF) at RT and 4⁰C in the presence and 
without PI. We conclude that PI is essential for maintaining stable enzyme activities in saliva and GCF.
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INTRODUCTION
A biomarker is defined as an indicator of normal bi-
ological, pathogenic processes, or pharmacological 
responses to a therapeutic or other health care inter-
vention (Atkinson et al., 2001). Several constituents 
of saliva and gingival crevicular fluid (GCF) have 
been characterized as biomarkers, notably several 
enzymes that are proving to be very useful in screen-
ing, diagnosis and tooth movement study (Nomura 
et al., 2012). As certain enzymes in saliva and GCF 
have short half-lives, they need to be analysed im-
mediately after collection. However, there are oth-
ers enzymes that remain stable after longer periods 
after collection, even at room temperature (~25⁰ C) 
(Koh and Koh, 2007). Limitations in enzymological 
analysis are logistic and financial, and collection and 
preparation of sample procedures has made immedi-
ate sample analysis impossible. Unstable tempera-
ture and/or bacterial contamination due to complex 
procedures affect the enzymological activities of sa-
liva and GCF samples during sampling and storage 
(Rohaya et al., 2010). Therefore, an optimized stor-
age procedure prior to sample analysis is necessary.1132 NURFATHIHA ABU KASIM ET AL.
The  major  enzyme  constituents  of  saliva  were 
identified  as  biomarkers  for  diagnostic  purposes 
(Koh and Koh, 2007), and salivary analysis is becom-
ing an important tool in detecting physiological and 
pathological changes (Amerongen et al., 2004). Sa-
liva is an oral fluid found in the oral cavity that is se-
creted by major and minor salivary glands. It is 99% 
water and contains electrolytes (sodium, potassium, 
calcium, chloride, magnesium) and proteins (Patri-
cia et al., 2008; Lima et al., 2010). Human salivary 
glands secrete approximately 500 – 1500 mL/day sa-
liva in response to sympathetic and parasympathet-
ic stimulations (Chiappin et al., 2007; Pfaffe et al., 
2011). Saliva also contains non-salivary constituents 
derived from gingival crevicular fluid, expectorated 
bronchial secretions, serum, blood cells from oral 
wounds, bacteria and bacterial products, fungi and 
viruses, desquamated epithelial cells and food debris 
(Nomura et al., 2012). Therefore, saliva plays an im-
portant role in oral health and homeostasis (Chiap-
pin et al., 2007).
GCF is an exudate that flows into the oral cav-
ity from the periodontal pocket (Lamster and Ahlo, 
2007). It is produced as a result of reaction between 
bacterial biofilm adherent to the tooth surface and 
the  cell  of  the  periodontal  tissue  (Pradeep  et  al., 
2009). Many of the components of GCF, such as cy-
tokines,  interleukins,  enzymes  and  prostaglandins 
have  been  characterized  as  biomarkers.  These  bi-
omarkers serve as diagnostic or prognostic markers 
of periodontal disease, oral health and healing after 
therapy (Subrahmanyam and Sangeetha, 2003; Pra-
deep et al., 2009). GCF is composed of substances 
derived from serum, leukocytes, structural cells of 
the periodontium and oral bacteria. The content of 
GCF reflects immune reactions and host-parasite in-
teractions (Gastel et al., 2011).
Lactate  dehydrogenase  (LDH),  aspartate  ami-
notransferase  (AST),  tartrate  resistant  acid  phos-
phatase (TRAP) and alkaline phosphatase (ALP) in 
human saliva and GCF have the potential to serve as 
biological marker for orthodontic tooth movement 
(OTM) monitoring (Rohaya et al., 2008; Rohaya et 
al., 2009; Rohaya et al., 2011). AST is a cytoplasmic 
enzyme  present  in  many  cells  (Paolantonio  et  al., 
2000). Cell damage and cell death releases AST into 
extracellular fluid and can be readily assayed in the 
oral cavity, in both GCF and saliva. LDH is a cytoplas-
mic enzyme which catalyses the reversible oxidation 
reaction of lactate to pyruvate (Numabe et al., 2004). 
After cell death, LDH is released into the extracellu-
lar environment. Hence, LDH activity levels exhibit 
positive correlation with tissue inflammation during 
gingivitis and tissue destruction caused by periodon-
titis in human (Serra et al., 2003). ALP is an enzyme 
related to tissue mineralization that is synthesized 
and released by dental pulp cells such as fibroblasts 
and odontoblast (Perinetti et al., 2004). ALP can also 
be used as biochemical marker to determine oste-
oblast activity since it is present on the fragments of 
plasma membranes of osteoblast cells (Huang et al., 
2010). TRAP is a metallophosphoesterase known to 
play a role in iron transport, generation of reactive 
oxygen species, osteopontin phosphatase and is a dif-
ferentiation factor of hematopoietic and osteoblastic 
cells. TRAP is expressed by osteoclasts, bone-resorb-
ing cells, and certain subpopulations of monocytes/
macrophages  and  dendritic  cells  (Ljusberg,  2005). 
Bone resorption during orthodonthic treatment is 
accompanied by elevated acid phosphatase activities 
in GCF and saliva (Insoft, 1996).
In this study, the stability of LDH, AST, TRAP 
and  ALP  activities  from  human  saliva  and  GCF 
samples in the presence and without the addition of 
protease inhibitor (PI) at three different temperatures 
(room temperature (25 ⁰C), 4 °C and -20 °C) after 12 
h, 24 h, 48 h, 72 h, one week and two weeks were 
investigated. The results of this study will provide 
information about the suitability of temperature at 
different storage periods and the addition of protease 
inhibitor to preserve enzyme activity in saliva and 
GCF samples. 
MATERIALS AND METHODS
Sample collection
This study was conducted at School of Biosciences 
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ate Clinic, Department of Orthodontic, Faculty of 
Dentistry,  Universiti  Kebangsaan  Malaysia.  Saliva 
and GCF samples were collected from nine healthy 
subjects (n=9) that fulfilled the following criteria: 
no  systemic  illness,  non-smokers,  no  use  of  any 
form of inflammatory drugs before the beginning 
of the study and good oral hygiene and periodontal 
health.
Saliva collection
Saliva was collected in a sterile 15 mL centrifuge 
tube.  Before  saliva  collection,  subjects  were  told 
not to perform any oral activities for 90 minutes in 
order to collect unstimulated saliva. Subjects were 
asked to rinse their mouth with sterile water prior to 
spitting. After collection, the tube was centrifuged 
Table 1. Percentage of aspartate aminotransferase (AST) in the presence and absence of protease inhibitor in saliva at room temperature, 
4⁰C and -20⁰C for various time of storage (n=9).
Time Percentage of AST activity 
with PI (%)
Percentage of AST activity 
without PI (%)
Percentage of AST activity with PI vs 
Percentage of AST activity without PI 
(%)
RT 4⁰C -20⁰C RT 4⁰C -20⁰C RT 4⁰C -20⁰C
0 h 100.0±0.4 100.0±0.4 100.0±0.4 100.0±0.4 100.0±0.4 100.0±0.4 ♦♦ ♦♦ ♦♦
12 h 94.0±0.2 102.0±0.9 121.0±2.0 151.0±1.9 122.0±1.2 96.0±1.8 ♦♦ ♦♦ ♦♦
24 h 100.0±0.7 108.0±0.8 110.0±0.4 129.0±1.3 121.0±1.2 122.0±1.3 ♦♦ ♦♦ ♦♦
48 h 80.0±0.6• 94.0±0.6• 101.0±0.4 101.0±1.1 99.0±1.2 103.0±1.0 ♦♦ ♦♦ ♦♦
72 h 104.0±0.5* 115.0±0.4* 109.0±0.3 131.0±1.3 105.0±1.2 108.0±1.1 ♦♦ ♦♦ ♦♦
1 week 92.0±0.4• 83.0±0.4• 82.0±0.2 99.0±0.7 113.0±1.9 89.0±0.7 ♦♦ ♦♦ ♦♦
2 week 126.0±0.7* 132.0±0.5* 136.0±0.5* 163.0±1.2* 111.0±0.9 130.0±1.4* ♦♦ ♦♦ ♦♦
Data represent the percentage (%) of AST activity ± SEM for 0, 12, 24, 48, 72 h, 1 and 2 weeks (0 h is the control) at three different tem-
perature; RT, 4⁰C and -20⁰C. * = significant increase (bold), •= significant decrease (italic, bold), ♦ = significant, ♦♦ = not significant.
Table 2. Percentage of aspartate aminotransferase (AST) in the presence and absence of protease inhibitor in GCF at room temperature, 
4⁰C and -20⁰C for various time of storage (n=9).
Time
Percentage of AST activity 
with PI (%)
Percentage of AST activity 
without PI (%)
Percentage of AST activity with 
PI vs Percentage of AST activity 
without PI (%)
RT 4⁰C -20⁰C RT 4⁰C -20⁰C RT 4⁰C -20⁰C
0 h 100.0±0.2 100.0±0.2 100.0±0.2 100.0±0.2 100.0±0.2 100.0±0.2 ♦♦ ♦♦ ♦♦
12 h 109.0±0.3 117.0±0.4 114.0±0.4 135.0±0.4 124.0±0.3 124.0±0.2 ♦♦ ♦♦ ♦♦
24 h 283.0±0.5* 290.0±0.5* 165.0±0.5* 326.0±0.7* 292.0±0.8* 306.0±0.7* ♦♦ ♦♦ ♦♦
48 h 260.0±0.7* 266.0±0.3* 154.0±0.7* 268.0±0.2* 252.0±0.6* 240.0±0.8* ♦♦ ♦♦ ♦♦
72 h 284.0±0.9* 308.0±0.3* 161.0±0.5* 302.0±0.2* 242.0±0.3* 250.0±0.5* ♦♦ ♦♦ ♦♦
1 week 86.0±0.2 92.0±0.3 87.0±0.5 75.0±0.1 80.0±0.1 84.0±0.1 ♦♦ ♦♦ ♦♦
2 week 104.0±0.1 104.0±0.3 84.0±0.3 133.0±0.4* 138.0±0.5 119.0±0.2 ♦ ♦ ♦♦
Data represent the percentage (%) of AST activity ± SEM for 0, 12, 24, 48, 72 hour, 1 and 2 weeks, at three different temperature; RT, 4⁰C 
and -20⁰C. * = significant increase (bold), •= significant decrease (italic, bold), ♦ = significant, ♦♦ = not significant1134 NURFATHIHA ABU KASIM ET AL.
for 10 min at 1000 xg (4 ⁰C). The supernatant was 
transferred into a new centrifuge tube and enzyme 
activities was determined.
Gingival crevicular fluid (GCF) collection
GCF was collected using periopaper (Proflow, USA) 
from the gingival sulcus of canine teeth. Each peri-
opaper strip was inserted 1-2 mm into the gingival 
crevice of test teeth and was left in situ for 60 s. 
Then, a total of three periopapers from each subject 
were placed into a 1.5 mL microcentrifuge tube con-
taining 1280 µL bovine serum albumin (0.01 mg/
mL). The tube was centrifuged for 10 min at 400 
xg (4⁰C), in a microcentrifuge (Hettich Zentrifugen 
Mikro 22R) to elute the GCF component.
Table 3. Percentage of lactate dehydrogenase (LDH) in the presence and absence of protease inhibitor in saliva at room temperature, 
4⁰C and -20⁰C for various time of storage (n=9).
Time
Percentage of LDH activity 
with PI (%)
Percentage of LDH activity 
without PI (%)
Percentage of LDH activity with PI vs 
Percentage of LDH activity without PI 
(%)
RT 4⁰C -20⁰C RT 4⁰C -20⁰C RT 4⁰C -20⁰C
0 h 100.0±0.3 100.0±0.3 100.0±0.3 100.0±0.3 100.0±0.3 100.0±0.3 ♦♦ ♦♦ ♦♦
12 h 71.0±0.8 101.0±0.5 95.0±0.7 80.0±0.5 95.0±0.7 95.0±0.7 ♦♦ ♦♦ ♦♦
24 h 89.0±0.7 87.0±0.5 95.0±0.6 85.0±0.7 85.0±0.6 85.0±0.7 ♦♦ ♦♦ ♦♦
48 h 79.0±0.6 84.0±0.7 90.0±0.6 91.0±0.7 93.0±0.7 87.0±0.6 ♦♦ ♦♦ ♦♦
72 h 96.0±0.8 99.0±0.7 98.0±0.6 100.0±0.7 95.0±0.6 99.0±0.7 ♦♦ ♦♦ ♦♦
1 week 81.0±0.4• 88.0±0.7 90.0±0.6 123.0±0.2* 75.0±0.5• 88.0±0.6 ♦ ♦ ♦♦
2 week 186.0±0.8* 93.0±0.5 136.0±1.9 133.0±0.1* 72.0±0.5• 79.0±0.5• ♦ ♦ ♦
Data represent the percentage (%) of LDH activity ± SEM for 0, 12, 24, 48, 72 hour, 1 and 2 weeks at three different temperature; RT, 
4⁰C and -20⁰C. * = significant increase (bold), •= significant decrease (italic, bold), ♦ = significant, ♦♦ = not significant
Table 4. Percentage of lactate dehydrogenase (LDH) in the presence and absence of protease inhibitor in GCF at room temperature, 4⁰C 
and -20⁰C for various time of storage (n=9)
Time
Percentage of LDH activity 
with PI (%)
Percentage of LDH activity 
without PI (%)
Percentage of LDH activity with PI vs 
Percentage of LDH activity without 
PI (%)
RT 4⁰C -20⁰C RT 4⁰C -20⁰C RT 4⁰C -20⁰C
0 h 100.0±0.3 100.0±0.3 100±0.33 100.0±0.3 100.0±0.3 100.0±0.3 ♦♦ ♦♦ ♦♦
12 h 89.0±0.2 96.0±0.1 91±0.19 92.0±0.1 91.0±0.2 89.0±0.1 ♦♦ ♦♦ ♦♦
24 h 95.0±0.2 93.0±0.2 102±0.11 131.0±1.3 94.0±0.3 92.0±0.2 ♦♦ ♦♦ ♦♦
48 h 89.0±0.3 94.0±0.2 83±0.14 87.0±0.2 91.0±0.1 91.0±0.2 ♦♦ ♦♦ ♦♦
72 h 114.0±0.1 105.0±0.4 100±0.65 139.0±0.7 96.0±0.6 98.0±0.2 ♦♦ ♦♦ ♦♦
1 week 85.0±0.2• 87.0±0.1 84±0.16• 83.0±0.2• 58.0±0.3• 84.0±0.3• ♦ ♦ ♦♦
2 week 84.0±0.2• 51.0±0.8• 90±0.25• 84.0±0.2• 70.0±0.1• 77.0±0.5• ♦♦ ♦♦ ♦♦
Data represent the percentage (%) of LDH activity ± SEM for 0, 12, 24, 48, 72 hour, 1 and 2 week, at three different temperature; RT, 
4⁰C and -20⁰C. * = significant increase (bold), •= significant decrease (italic, bold), ♦ = significant, ♦♦ = not significantENZYME STABILITY WITH PROTEASE INHIBITOR 1135
Sample storage
Both saliva and GCF samples were divided equally 
into two ~700 µL. Protease inhibitor (GE Health-
care) was added to one of the samples at a ratio of 
1:100 and subsequently divided into 18 microcentri-
fuge tubes (0.5 mL). The samples with and without 
protease inhibitor were stored at room temperatures 
(RT), 4°C, and -20°C. ALP, TRAP, LDH and AST ac-
tivities were measured after 0 h, 12 h, 24 h, 48 h, 72 
h, 1 and 2 weeks of storage. Measurements of ALP, 
TRAP, LDH and AST activities were performed in 
triplicate.
Enzyme assay  
Alkaline phosphatase (ALP) and tartrate resistant 
acid phosphatase assay (TRAP)
ALP  activities  in  saliva  and  GCF  samples  were 
measured spectrophotometrically using microplate 
Table 5. Percentage of tartrate resistant acid phosphatase (TRAP) in the presence and absence of protease inhibitor in saliva at room 
temperature, 4⁰C and -20⁰C for various time of storage (n=9)
Time
Percentage of TRAP activity 
with PI (%)
Percentage of TRAP activity 
without PI (%)
Percentage of TRAP activity with PI vs 
Percentage of TRAP activity without 
PI (%)
RT 4⁰C -20⁰C RT 4⁰C -20⁰C RT 4⁰C -20⁰C
0 h 100.0±0.5 100.0±0.5 100.0±0.5 100.0±0.5 100.0±0.5 100.0±0.5 ♦♦ ♦♦ ♦♦
12 h 97.0±0.1 101.0±0.1 117.0±3.5 103.0±1.3 86.0±0.3 94.0±1.6 ♦♦ ♦♦ ♦♦
24 h 99.0±0.1 91.0±1.5 92.0±2.9 99.0±2.2 85.0±1.1 83.0±2.1 ♦♦ ♦♦ ♦♦
48 h 52.0±0.3• 57.0±0.8• 87.0±1.0 48.0±0.4• 60.0±0.8• 66.0±2.9 ♦♦ ♦♦ ♦♦
72 h 87.0±0.4• 83.0±0.9• 81.0±1.6 68.0±1.1• 73.0±0.7• 80.0±0.8 ♦♦ ♦♦ ♦♦
1 week 72.0±0.8• 55.0±0.3• 39.0±0.9 72.0±0.2• 75.0±0.5• 72.0±0.5• ♦♦ ♦ ♦
2 week 67.0±0.5• 75.0±2.7• 38.0±0.2• 56.0±0.3• 43.0±0.6• 38.0±0.1• ♦ ♦ ♦♦
Data represent the percentage (%) of TRAP activity ± SEM for 0, 12, 24, 48, 72 hour, 1 and 2 weeks, at three different temperature; RT, 
4⁰C and -20⁰C. * = significant increase (bold), •= significant decrease (italic, bold), ♦ = significant, ♦♦ = not significant
Table 6. Percentage of tartrate resistant acid phosphatase (TRAP) in the presence and absence of protease inhibitor in GCF at room 
temperature, 4⁰C and -20⁰C for various time of storage (n=9)
Time
Percentage of TRAP activity 
with PI (%)
Percentage of TRAP activity 
without PI (%)
Percentage of TRAP activity with PI vs 
Percentage of TRAP activity without 
PI (%)
RT 4⁰C -20⁰C RT 4⁰C -20⁰C RT 4⁰C -20 ⁰C
0 h 100.0±0.2 100.0±0.2 100.0±0.2 100.0±0.2 100.0±0.2 100.0±0.2 ♦♦ ♦♦ ♦♦
12 h 83.0±0.1 82.0±0.1 87.0±0.1 101.0±0.2 85.0±0.1 79.0±0.1 ♦♦ ♦♦ ♦♦
24 h 76.0±0.1 74.0±0.1 71.0±0.1 138.0±1.9 52.0±0.2 84.0±0.1 ♦♦ ♦♦ ♦♦
48 h 53.0±0.2 80.0±0.2 76.0±0.1 127.0±0.2 39.0±0.1• 67.0±0.1 ♦♦ ♦♦ ♦♦
72 h 44.0±0.1• 34.0±0.1• 78.0±0.1 76.0±0.1 49.0±0.3• 59.0±0.2 ♦ ♦♦ ♦♦
1 week 61.0±0.1• 66.0±0.1• 70.0±0.1• 65.0±0.1• 57.0±0.1• 63.0±0.1• ♦♦ ♦♦ ♦♦
2 week 86.0±0.1• 84.0±0.1• 85.0±0.1• 126.0±0.7 84.0±0.1 • 80.0±0.1• ♦ ♦♦ ♦♦
Data represent the percentage (%) of TRAP activity ± SEM for 0, 12, 24, 48, 72 hour, 1 and 2 weeks, at three different temperature; RT, 
4⁰C and -20⁰C. * = significant increase (bold), •= significant decrease (italic, bold), ♦ = significant, ♦♦ = not significant1136 NURFATHIHA ABU KASIM ET AL.
reader (Varioskan, Thermo Fisher Scientific) at 405 
nm. The samples were added into a mixture con-
taining p-nitrophenyl phosphate (1mM), mannitol 
(20mM), magnesium chloride (0.3 mM) and car-
bonate buffer (pH 9.8), and were incubated at 30°C 
for 30 min.
For TRAP activity, saliva and GCF samples were 
incubated at 37 °C for 60 min in a mixture contain-
ing p-nitrophenyl phosphate (10 mM), ascorbic acid 
(1 mM), FeCl3 (0.1 mM), potassium chloride (0.15 
M), sodium tartrate (10 mM), sodium acetate buffer 
pH 5.8 (0.1 M) and 0.1% (v/v) Triton X-100. Absorb-
ance was determined at 405 nm. A standard curve 
employing 1 mM of p-nitrophenol solution was used 
to convert absorbance into enzyme unit activity (1 
U = 1 μmol of p-nitrophenol released per minute at 
37°C).
Table 7. Percentage of alkaline phosphatase (ALP) in the presence and absence of protease inhibitor in saliva at room temperature, 4⁰C 
and -20⁰C for various time of storage (n=9)
Time
Percentage of ALP activity 
with PI (%)
Percentage of ALP activity 
without PI (%)
Percentage of ALP activity with PI vs 
Percentage of ALP activity without PI 
(%)
RT 4⁰C -20⁰C RT 4⁰C -20⁰C RT 4⁰C -20⁰C
0 h 100.0±0.1 100.0±0.1 100.0±0.1 100.0±0.1 100.0±0.1 100.0±0.1 ♦♦ ♦♦ ♦♦
12 h 58.0±0.1 73.0±0.1 92.0±0.3 122.0±0.5 130.0±0.1 132.0±0.3 ♦♦ ♦♦ ♦♦
24 h 92.0±0.1 96.0±0.2 100.0±0.5 157.0±0.5 115.0±0.2 89.0±0.20 ♦♦ ♦♦ ♦♦
48 h 71.0±0.1 101.0±0.3 124.0±0.7 140.0±0.1 106.0±0.3 113.0±0.27 ♦ ♦♦ ♦♦
72 h 75.0±0.1 100.0±0.3 105.0±0.5 167.0±0.1* 132.0±0.3 131.0±0.20 ♦ ♦♦ ♦♦
1 week 83.0±0.1 75.0±0.1 102.0±0.8 167.0±0.1* 122.0±0.1 105.0±0.16 ♦ ♦♦ ♦♦
2 week 82.0±0.2 86.0±0.2 94.0±0.7 179.0±0.2* 148.0±0.2 129.0±0.28 ♦ ♦♦ ♦♦
Data represent the percentage (%) of ALP activity ± SEM for 0, 12, 24, 48, 72 hour, 1 and 2 weeks at three different temperature; RT, 4⁰C 
and -20⁰C. * = significant increase (bold), •= significant decrease (italic, bold), ♦ = significant, ♦♦ = not significant
Table 8. Percentage of alkaline phosphatase (ALP) in the presence and absence of protease inhibitor in GCF at room temperature, 4⁰C 
and -20⁰C for various time of storage (n=9)
Time
Percentage of ALP activity 
with PI (%)
Percentage of ALP activity 
without PI (%)
Percentage of ALP activity with PI vs 
Percentage of ALP activity without PI 
(%)
RT 4⁰C -20⁰C RT 4⁰C -20⁰C RT 4⁰C -20⁰C
0 h 100.0±1.0 100.0±1.0 100.0±1.0 100.0±1.0 100.0±1.0 100.0±1.0 ♦♦ ♦♦ ♦♦
12 h 75.0±0.2 105.0±0.3 108.0±0.3 80.0±0.6 95.0±0.9 103.0±0.7 ♦♦ ♦♦ ♦♦
24 h 101.0±0.2 88.0±0.3 104.0±0.2 95.0±0.8 89.0±0.8 86.0±0.4 ♦♦ ♦♦ ♦♦
48 h 162.0±0.6 151.0±0.4 130.0±0.3 132.0±0.9* 111.0±0.4* 99.0±0.8 ♦♦ ♦♦ ♦♦
72 h 144.0±0.7 163.0±0.5 150.0±0.4 111.0±0.9* 124.0±0.7* 125.0±0.8 ♦♦ ♦♦ ♦♦
1 week 169.0±0.1* 188.0±0.5* 174.0±0.5* 127.0±0.9* 138.0±1.0* 141.0±1.1* ♦♦ ♦♦ ♦♦
2 week 216.0±0.4* 244.0±0.7* 208.0±0.9* 162.0±0.7* 146.0±0.5* 157.0±1.1* ♦♦ ♦♦ ♦♦
Data represent the percentage (%) of ALP activity ± SEM for 0, 12, 24, 48, 72 hour, 1 and 2 weeks, at three different temperature; RT, 4⁰C 
and -20⁰C. * = significant increase (bold), •= significant decrease (italic, bold), ♦ = significant, ♦♦ = not significantENZYME STABILITY WITH PROTEASE INHIBITOR 1137
Lactate dehydrogenase (LDH) and aspartate  
aminotransferase (AST) assay
LDH and AST activities were determined spectro-
photometrically at 340 nm, using a microplate read-
er (Varioskan, Thermo Fisher Scientific). For LDH, 
samples were added into a test tube containing 16.2 
mM sodium pyruvate, 0.54 M phosphate buffer (pH 
7.4) and 0.2 mM NADH after 5 min incubation at 
30⁰C. Changes in the absorbance was recorded eve-
ry 30 s for 3 minutes.
For AST activity, samples were assayed for 4 min 
in a mixture of 0.15 M L-aspartate, 0.1 mM 2-ox-
oglutarate, 0.2 mM NADH, 0.4 U malate dehydro-
genase and 0.1 M sodium phosphate buffer (pH 7.4) 
after 5 min incubation at 30⁰C. One unit of enzyme 
activity = 1 mol NADH consumed per min at 30 ⁰C. 
Specific activities of LDH and AST are expressed in 
units of activity (U) per mg protein.
Data analysis
All the specific activity results were converted into 
percentage; 0 hour was considered as 100 % activity. 
The data obtained were analysed with paired t-test, 
using Statistical Package for Social Sciences (SPSS) 
ver. 20 software (SPSS Inc., USA); p<0.05 was con-
sidered as significant.
RESULTS
Aspartate aminotransferase (AST) activity in saliva 
and GCF samples
Significant increases (p<0.05) were observed for sali-
vary AST activity in the presence of PI (for 72 h at 
RT and 4⁰C; 2 weeks at RT, 4⁰C and -20⁰C) and also 
without PI in saliva after storage for 2 weeks at RT 
and -20 ⁰C (Table 1). A significant decrease in AST 
activity (p<0.05) was observed after the addition of 
PI in saliva stored for 48 h and 1 week at RT and 
4⁰C (Table 1). AST activity significantly increased 
(p<0.05) with and without the addition of PI in GCF, 
stored for 24 h and 72 h at RT, 4⁰C and -20⁰C, and for 
2 weeks at RT without PI (Table 2). 
Lactate dehydrogenase (LDH) activity in saliva and 
GCF samples
LDH activity increased significantly (p<0.05) in the 
presence of PI after 2 weeks at RT (Table 3), and 
without PI, in saliva stored for 1 and 2 weeks at RT 
(Table 3). A significant decrease in LDH activity was 
observed in the presence of PI in samples stored for 
1 week at RT (Table 3). Without addition of PI a sig-
nificant decrease (p<0.05) was observed in samples 
kept for 1 and 2 weeks at 4⁰C (Table 3). There were no 
significant increase (p>0.05) in LDH activity neither 
with nor without addition of PI in GCF (Table 4). In 
GCF, LDH activity significantly decreased with and 
without the addition of PI after 1 and 2 weeks of stor-
age at all temperatures, except at 4⁰C at 1 week with 
PI (Table 4).
Tartrate resistant acid phosphatase (TRAP) activity 
in saliva and GCF samples
There were no significant increases (p>0.05) in TRAP 
activity with and without the addition of PI in saliva 
and GCF stored at all examined temperatures (Table 
5 and 6). The addition of PI to the saliva caused a sig-
nificant decrease in enzyme activity after 48 h, 72 h, 
1 and 2 weeks at RT and 4⁰C, and after 2 weeks at -20 
⁰C (Table 5). Significant decreases (p<0.05) in TRAP 
activity were observed without the addition of PI to 
saliva, starting from 48 h at all investigated tempera-
tures except at -20⁰C where the decrement started 
after 1 week of storage (Table 5). In the GCF, the ac-
tivity of TRAP decreased significantly (p<0.05) with 
the addition of PI, starting from 72 h at RT and 4 ⁰C, 
whereas at -20 ⁰C it decreased after 1 week. Without 
the addition of PI, significant decrease (p<0.05) was 
observed in samples kept at RT for 1 week at 4°C and 
starts from 48 h and -20 °C starts from 1 week (Table 
6).
Alkaline phosphatase (ALP) activity in saliva and 
GCF samples
No significant decreases (p>0.05) were observed for 
ALP activity in saliva stored in the presence of PI 
for all investigated parameters (Table 7). However, a 1138 NURFATHIHA ABU KASIM ET AL.
significant increase (p<0.05) was observed for ALP 
activity in the absence of PI, starting from 72 h at 
RT (Table 7). In GCF there was not a significant de-
crease (p>0.05) in ALP activity after addition of PI 
for all investigated parameters. A significant increase 
(p<0.05) in ALP activity was observed with the addi-
tion of PI, starting from the 1st week at all tempera-
tures (Table 8), and without the addition of PI at RT 
and at 4⁰C, starting from 48 h and at -20⁰C starting 
from the 1st week of storage.
Enzymatic activity in saliva and GCF
The  significant  changes  in  AST,  LDH,  TRAP  and 
ALP activities with and without addition of PI in sa-
liva and GCF storage at various temperatures (RT, 4 
⁰C and -20 ⁰C) were also analysed. There was no sig-
nificant difference (p>0.05) of AST activity in saliva 
(Table 1). The analysis shows significant differences 
(p<0.05) in LDH activity (at RT and 4⁰C for 1 week 
and 2 weeks, -20⁰C for week 2; Table 3), TRAP activ-
ity (at RT for 2 week, at 4⁰C for 1 and 2 weeks and 
-20⁰C for 1 week; Table 5) and ALP activity (at RT 
starts from 48 h; Table 7) in saliva.
There were significant differences (p<0.05) for 
AST activity (at RT and 4⁰C after 2 weeks (Table 2), 
LDH activity at RT and 4 ⁰C at 1 week (Table 4) and 
TRAP activity at RT, 72 h and 2 weeks (Table 6) in 
GCF. ALP activity showed no significant difference 
(p>0.05) (Table 8).
DISCUSSION
Study on the stability of enzymes in saliva and GCF 
samples in the presence protease inhibitor at various 
temperatures can provide information as to optimal 
sample management.
Rohaya et al. (2010) examined the stability of hu-
man salivary LDH activity in three different storage 
media (EDTA, glycerol, and PEG) at room tempera-
ture (RT), 4⁰C, and -20⁰C for one and two weeks. In 
contrast with our study, protease inhibitor (PI) was 
added to saliva and GCF samples at three different 
temperature (RT, 4⁰C, and -20⁰C) for certain times 
of storage (12 h, 24 h, 48 h, 72 h, 1 week and 2 week). 
The present study observed the stability of enzymes 
that are involved in tooth movement processes - AST, 
LDH, TRAP and ALP.
In saliva, AST activity did not show significant 
difference  (p<0.05)  between  addition  and  without 
addition of PI (Table 1). The data suggests that PI is 
not important for maintaining AST activity. In con-
trast, LDH (Table 3) and TRAP (Table 5) activities 
showed significant differences (p<0.05) between in 
the presence and absence of PI when stored for more 
than 1 week at the three temperatures. ALP activ-
ity displayed significant difference (p<0.05) in the 
presence and absence of PI at RT, while at 4⁰C and 
-20⁰C a significant differences (p>0.05) was not ob-
served (Table 7). Therefore, PI is needed when saliva 
is stored for more than 1 week at RT, 4⁰C and -20⁰C 
to maintain LDH and TRAP activity, and at RT to 
maintain ALP activity.
For  GCF,  there  were  significant  differences 
(p<0.05) in the presence and absence of PI for a stor-
age more than 72 h for AST, LDH and TRAP at RT 
and AST and LDH at 4⁰C. At -20⁰C, all the enzymes 
did not show any significant difference (p>0.05) in 
the presence and absence of PI. Therefore, PI is not 
necessary for the GCF sample to be stored at -20⁰C 
(Tables 2, 4 and 6). However, the temperature of the 
storage should be taken into consideration since dif-
ferent temperatures can stabilize enzyme activities 
for different times of storage, either with or without 
addition of PI (Tables 1 – 8; Koh and Koh, 2007). It 
is well known that storage at RT often causes protein 
degradation and that enzymes can be deactivated by 
microbial growth (Rohaya et al., 2010). In addition, 
some enzymes will lose their activity when frozen 
due to changes in their structures (Katherine et al., 
2000). The addition of PI is required for longer sam-
ples storage, i.e. saliva and GCF especially at RT (Ta-
ble 2-3; Table 5-7).
Previous study on stability of salivary LDH with 
EDTA, glycerol and PEG by Rohaya et al. (2010), 
showed that PEG as the best storage media for sali-
vary  LDH,  whereas,  EDTA  only  suitable  at  room ENZYME STABILITY WITH PROTEASE INHIBITOR 1139
temperature  for  one  week  time  and  glycerol  only 
suitable in the cold. Moreover, they also reported 
that salivary LDH activity without addition of any 
chemicals  was  significantly  decreased  (p<0.01)  af-
ter a week. This finding was similar with current re-
search where salivary LDH activity decreased with 
time after storage at 4⁰C and -20⁰C. A study by De La 
Pena et al. (2004) showed that salivary LDH can be 
stored up to 3 month at 4⁰C without addition of any 
stabilizer or inhibitor. At -20⁰C, they found a signifi-
cant decrease (p<0.05) in LDH activity after only 30 
min of storage. 
In the study by Halleen (2006), TRAP activity 
was stabilized up to 2 days at RT, 3 days at 4⁰C and 
1 month at -20⁰C. These differences may due to the 
different sample used in these two studies. Previous 
study used a serum sample (Halleen, 2006) while we 
used saliva and GCF. To date, there are no studies and 
information regarding the stability of enzyme activi-
ties, especially in saliva and GCF. Therefore, more 
studies should be conducted as sample handling can 
affect enzymes stability. 
CONCLUSION
The findings of our study suggested that PI can stabi-
lize enzymes activities in saliva and GCF, thus addi-
tion of PI is essential for the effective storage of AST, 
LDH, TRAP and ALP in samples.
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